Because of the importance of bradykinin in improving heart function in
some conditions or in enhancing glucose uptake by skeletal muscle, we
investigated kininases in these tissues. In P-3 fraction of the heart
and skeletal muscles, angiotensin I-converting enzyme (ACE) and neutr
al endopeptidase 24.11 (NEP) are the major kininases, as determined fi
rst with specific substrates and second with bradykinin. ACE activity
was highest in guinea pig heart (2.7 +/- 0.07 mu mol . h(-1). mg prote
in(-1)) but decreased in other species in this order: dog atrium, rat
heart, dog ventricle, and human atrium. The specific activity of NEP w
as lower: 0.45 mu mol . h(-1). mg protein(-1) in cultured neonatal car
diac myocytes and varying between 0.12 and 0.05 mu mol . h(-1). mg pro
tein(-1) in human, dog, rat, and guinea pig heart. In the skeletal mus
cle P-3, ACE was most active in guinea pig and rat (1.2 and 1.1 mu mol
. h(-1). mg protein(-1), respectively) but less so in dog (0.09 mu mo
l . h(-1). mg protein(-1)). NEP activity was higher in dog P-3 (0.28 m
u mol . h(-1). mg protein(-1)) but lower in rat and guinea pig (0.19 a
nd 0.1 mu mol . h(-1). mg protein(-1), respectively). Continuous densi
ty gradient centrifugation enriched NEP activity in dog and rat (from
0.3 to 1.0 and 0.49 mu mol . h(-1). mg protein(-1), respectively). Imm
unoprecipitation with antiserum to purified NEP proved the specificity
of the rat enzyme. Bradykinin (0.1 mmol/l) was inactivated in the pre
sence and absence of inhibitors by rat skeletal muscle NEP, as measure
d by high-performance liquid chromatography. Here, 36% of the activity
was caused by NEP and 19% by ACE. In radioimmunoassay (bradykinin 10
nmol/l), 46 and 55% of kininase in rat and dog skeletal muscle P-3, re
spectively, was due to ACE; 36 and 28%, respectively, was due to NEP.
Aside from these enzymes, an aminopeptidase in rat P-3 also inactivate
s bradykinin. Thus, in conclusion, heart and skeletal muscle membranes
contain kininase II-type enzymes, but their, activity depends on the
species.